RT Journal Article
T1 Association of Kinesiophobia with Catastrophism and Sensitization-Associated Symptoms in COVID-19 Survivors with Post-COVID Pain
A1 Herrero Montes, Manuel
A1 Fernández de las Peñas, César
A1 Ferrer Pargada, Diego
A1 Izquierdo Cuervo, Sheila
A1 Abascal Bolado, Beatriz
A1 Valera Calero, Juan Antonio
A1 Paras Bravo, Paula
AB Pain symptoms after the acute phase of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are present in almost 50% of COVID-19 survivors. The presence of kinesiophobia is a risk factor which may promote and perpetuate pain. This study aimed to investigate variables associated with the presence of kinesiophobia in a sample of previously hospitalized COVID-19 survivors exhibiting post-COVID pain. An observational study was conducted in three urban hospitals in Spain, including one hundred and forty-six COVID-19 survivors with post-COVID pain. Demographic (age, weight, height), clinical (intensity and duration of pain), psychological (anxiety level, depressive level, sleep quality), cognitive (catastrophizing), sensitization-associated symptoms, and health-related quality of life variables were collected in 146 survivors with post-COVID pain, as well as whether they exhibited kinesiophobia. Stepwise multiple linear regression models were conducted to identify variables significantly associated with kinesiophobia. Patients were assessed a mean of 18.8 (SD 1.8) months after hospital discharge. Kinesiophobia levels were positively associated with anxiety levels (r: 0.356, p < 0.001), depression levels (r: 0.306, p < 0.001), sleep quality (r: 0.288, p < 0.001), catastrophism (r: 0.578, p < 0.001), and sensitization-associated symptoms (r: 0.450, p < 0.001). The stepwise regression analysis revealed that 38.1% of kinesiophobia variance was explained by catastrophism (r2 adj: 0.329, B = 0.416, t = 8.377, p < 0.001) and sensitization-associated symptoms (r2 adj: 0.381, B = 0.130, t = 3.585, p < 0.001). Kinesiophobia levels were associated with catastrophism and sensitization-associated symptoms in previously hospitalized COVID-19 survivors with post-COVID pain. Identification of patients at a higher risk of developing a higher level of kinesiophobia, associated with post-COVID pain symptoms, could lead to better therapeutic strategies.
PB MDPI
SN 2075-4418
YR 2023
FD 2023-02-23
LK https://hdl.handle.net/20.500.14352/103532
UL https://hdl.handle.net/20.500.14352/103532
LA eng
NO Herrero-Montes, M.; Fernández-de-las-Peñas, C.; Ferrer-Pargada, D.; Izquierdo-Cuervo, S.; Abascal-Bolado, B.; Valera-Calero, J.A.; Paras-Bravo, P. Association of Kinesiophobia with Catastrophism and Sensitization-Associated Symptoms in COVID-19 Survivors with Post-COVID Pain. Diagnostics 2023, 13, 847. https://doi.org/10.3390/diagnostics13050847
NO 2022 Descuento MDPI (This article belongs to the Special Issue Musculoskeletal and Neuropathic Pain in COVID-19: Diagnosis and Management Challenge)
DS Docta Complutense
RD 6 abr 2025